United States HR 2087: Drug Price Transparency Act

Status: Subcommittee Hearings Held. (as of 2019-05-21)

State: United States · Session: 116 · Bill: HR 2087

Subjects: Administrative law and regulatory procedures, Civil actions and liability, Congressional oversight, Consumer affairs, Health care costs and insurance, Health information and medical records, Insurance industry and regulation, Medicare, Prescription drugs, Retail and wholesale trades

Sponsors: LLOYD DOGGETT, Vern Buchanan

View United States HR 2087 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.